Analysts expect Archer-Daniels-Midland to report Q3 2026 revenue of approximately $23.27 billion and an adjusted EPS of $1.63, with the stock currently trading at $79.04 against a consensus target of $81.75.
Investors are primarily focused on the performance of the Ag Services and Oilseeds segment, particularly crushing margins which have faced significant volatility over the past fiscal year.
The company is leveraging a new joint venture with CJ CheilJedang to bolster its animal nutrition footprint and improve cost competitiveness in feed-grade amino acids. This earnings report follows a period of portfolio optimization and internal control enhancements aimed at restoring investor confidence after previous accounting restatements.